Raffaele, F;
Claudia, M;
John, H;
(2019)
Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues.
Neurobiology of Aging
, 78
pp. 98-110.
10.1016/j.neurobiolaging.2019.02.006.
Preview |
Text
NBA_Review_Ferrari-Manzoni-Hardy_REVISED_Jan2019_without-Track.pdf - Accepted Version Download (931kB) | Preview |
Abstract
Frontotemporal lobar degeneration (FTLD) is the second most common form of dementia after Alzheimer's disease. The study and the dissection of FTLD is complex due to its clinical, pathological, and genetic heterogeneity. In this review, we survey the state-of-the-art genetics of familial FTLD and recapitulate our current understanding of the genetic architecture of sporadic FTLD by summarizing results of genome-wide association studies performed in FTLD to date. We then discuss the challenges of translating these heterogeneous genetic features into the understanding of the molecular underpinnings of FTLD pathogenesis. We particularly highlight a number of susceptibility processes that appear to be conserved across familial and sporadic cases (e.g., and the cellular waste disposal pathways, and immune system signaling) and finally describe cutting-edge approaches, based on mathematical prediction tools, highlighting novel intriguing risk pathways such as DNA damage response as an emerging theme in FTLD.
| Type: | Article |
|---|---|
| Title: | Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.neurobiolaging.2019.02.006 |
| Publisher version: | https://doi.org/10.1016/j.neurobiolaging.2019.02.0... |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Geriatrics & Gerontology, Neurosciences, Neurosciences & Neurology, Frontotemporal dementia, Frontotemporal lobar degeneration, Genetics, Pathways, Disease mechanism, Mendelian FTD, Sporadic FTD, FTD-GWAS, AMYOTROPHIC-LATERAL-SCLEROSIS, GROWTH-FACTOR, HEXANUCLEOTIDE REPEAT, CLINICAL-FEATURES, DEMENTIA INSIGHTS, MUTATION CARRIERS, TARDBP MUTATIONS, ESCRT-III, DISEASE, PROGRANULIN |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10084870 |
Archive Staff Only
 |
View Item |
